Summary Objective: To investigate the usefulness of the milk-to-plasma (M=P) ratio for assessing the risks for the breastfed infant associated with the maternal use of SSRIs. Data sources: Medline, Toxnet, Embase, Current Contents, and PsycInfo indexed articles from 1980 to September 2006. Study selection and data extraction: All studies reporting the M=P ratio in mothers taking SSRIs while breastfeeding or studies which such an information could be calculated from data reported in the article. Data synthesis: Higher M=P ratios were rarely associated with a clinically significant impact on the babies during the early phases of breastfeeding. Conclusions: So far no evidence-based information seems to support the hypothesis that SSRIs characterized by a M=P ratio <1.0 should be preferred. Hence, physicians should consider different parameters when attempting to choose the safest SSRI for the breastfeeding woman. These parameters might be represented by the number of well-documented published adverse event reports and the tendency of each SSRI of inducing in the infants serum concentrations that are elevated above 10% of average maternal serum levels. In any case, if the mother wishes to breastfeed her infant while taking a SSRI, the baby should be closely monitored in order to promptly detect any iatrogenic event. Keywords: Breastfeeding; lactation; milk=plasma ratio; safety; SSRIs.
SSRIs during breastfeeding: spotlight on milk-to-plasma ratio / Gentile, S.; Rossi, A.; Bellantuono, Cesario. - In: ARCHIVES OF WOMENS MENTAL HEALTH. - ISSN 1434-1816. - 10 (2):(2007), pp. 39-51.
SSRIs during breastfeeding: spotlight on milk-to-plasma ratio
BELLANTUONO, Cesario
2007-01-01
Abstract
Summary Objective: To investigate the usefulness of the milk-to-plasma (M=P) ratio for assessing the risks for the breastfed infant associated with the maternal use of SSRIs. Data sources: Medline, Toxnet, Embase, Current Contents, and PsycInfo indexed articles from 1980 to September 2006. Study selection and data extraction: All studies reporting the M=P ratio in mothers taking SSRIs while breastfeeding or studies which such an information could be calculated from data reported in the article. Data synthesis: Higher M=P ratios were rarely associated with a clinically significant impact on the babies during the early phases of breastfeeding. Conclusions: So far no evidence-based information seems to support the hypothesis that SSRIs characterized by a M=P ratio <1.0 should be preferred. Hence, physicians should consider different parameters when attempting to choose the safest SSRI for the breastfeeding woman. These parameters might be represented by the number of well-documented published adverse event reports and the tendency of each SSRI of inducing in the infants serum concentrations that are elevated above 10% of average maternal serum levels. In any case, if the mother wishes to breastfeed her infant while taking a SSRI, the baby should be closely monitored in order to promptly detect any iatrogenic event. Keywords: Breastfeeding; lactation; milk=plasma ratio; safety; SSRIs.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.